Kewaunee Scientific Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4928541048
USD
37.53
-0.07 (-0.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Pro-Dex, Inc.
Milestone Scientific, Inc.
Prenetics Global Ltd.
Wrap Technologies, Inc.
Kewaunee Scientific Corp.
Rockwell Medical, Inc.
VolitionRX Ltd.
Lucid Diagnostics, Inc.
Cardiff Oncology, Inc.
HeartBeam, Inc.
Cue Health, Inc.

Why is Kewaunee Scientific Corp. ?

1
Negative results in Jan 26
  • PRE-TAX PROFIT(Q) At USD 1.6 MM has Fallen at -59.38%
  • INTEREST(HY) At USD 2.17 MM has Grown at 37.62%
  • ROCE(HY) Lowest at 16.85%
2
Underperformed the market in the last 1 year
  • The stock has generated a return of 3.53% in the last 1 year, much lower than market (S&P 500) returns of 25.41%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Kewaunee Scientific Corp. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Kewaunee Scientific Corp.
3.53%
-0.15
55.80%
S&P 500
25.41%
1.92
13.25%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
15.01%
EBIT Growth (5y)
70.17%
EBIT to Interest (avg)
2.99
Debt to EBITDA (avg)
0.57
Net Debt to Equity (avg)
0.39
Sales to Capital Employed (avg)
3.04
Tax Ratio
21.66%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
49.14%
ROCE (avg)
18.08%
ROE (avg)
11.29%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
1.39
EV to EBIT
5.73
EV to EBITDA
4.36
EV to Capital Employed
1.32
EV to Sales
0.40
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
23.02%
ROE (Latest)
16.58%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 22.59 MM

NET SALES(9M)

At USD 210.6 MM has Grown at 28.95%

-17What is not working for the Company
PRE-TAX PROFIT(Q)

At USD 1.6 MM has Fallen at -59.38%

INTEREST(HY)

At USD 2.17 MM has Grown at 37.62%

ROCE(HY)

Lowest at 16.85%

NET PROFIT(Q)

Lowest at USD 0.69 MM

EPS(Q)

Lowest at USD 0.23

Here's what is working for Kewaunee Scientific Corp.

Net Sales
At USD 210.6 MM has Grown at 28.95%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Cash Flow
Highest at USD 22.59 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Depreciation
Highest at USD 1.6 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Kewaunee Scientific Corp.

Pre-Tax Profit
At USD 1.6 MM has Fallen at -59.38%
over average net sales of the previous four periods of USD 3.95 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD 0.69 MM has Fallen at -76.43%
over average net sales of the previous four periods of USD 2.94 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Interest
At USD 2.17 MM has Grown at 37.62%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Net Profit
Lowest at USD 0.69 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

EPS
Lowest at USD 0.23
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)